Contraceptive Technology Update
RSSArticles
-
Results of survey indicate unmet need for family planning at community health centers
Results of a recent survey at U.S. community health centers indicate an unmet need for more comprehensive family planning services at such facilities, according to a report issued by the Geiger Gibson /RCHN Community Health Foundation Research Collaborative and the Jacobs Institute of Women’s Health, all in Washington, DC.
-
Oral contraceptives reduce the risk of developing endometrial cancer
Taking oral contraceptives, even for just a few years, offers significant long-term protection against endometrial cancer, confirms a detailed re-analysis of all available evidence by British researchers. Data indicate that the longer a woman takes oral contraceptives, the greater her reduction in risk for the disease, the analysis states.
-
FDA approves first treatment for sexual desire disorder
The FDA has approved Addyi (flibanserin, Sprout Pharmaceuticals, Raleigh, NC) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. The drug is the first such treatment to be approved by the FDA for this condition.
-
Urinary tract infections, STIs misdiagnosed in EDs
Distinguishing between these syndromes can be challenging because of overlapping symptomatology (painful or difficult urination, frequency, urgency) and the fact that both are associated with abnormalities on urinalysis, researchers note.
-
Experts advise: Check screening schedule for chlamydia at your organization
Remember when an annual Pap smear for a young woman also provided a chance for routine chlamydia screening? Results from a University of Michigan study of five clinics indicate that when Pap smear schedules were revised in 2009, the number of annual chlamydia screenings dropped in women ages 16-21.
-
What impact does intimate partner violence have on reproductive decision-making?
In the current study, funded by the Department of Health and Human Services’ Agency for Healthcare Research and Quality, investigators used the Pregnancy Risk Assessment Monitoring System, a population-based surveillance system, to analyze data on more than 193,000 U.S. women with live births between 2004 and 2008.
-
New teen data — What it means for your practice
A new analysis of national data carries good news the percentage of teens who have experienced sexual intercourse has declined significantly.
-
Affordable Care Act makes impact on costs of many forms of birth control
Results of an analysis of a large national insurer’s prescription claims database indicate the average out-of-pocket expense for a pill prescription fell from $32.74 in the first six months of 2012 to $20.37 in the first six months of 2013, which is a 38% decline, while similar expenses for an intrauterine device insertion fell from $262.38 to $84.30, a 68% drop.
-
HPV vaccination: Many teens still not receiving the shot
The latest estimates indicate that 60% of adolescent girls and 42% of adolescent boys have received one or more doses of HPV vaccine.
-
Get CDC fact sheet on shigellosis
The Centers for Disease Control and Prevention have a patient information sheet on shigellosis. Shigellosis is a common diarrheal disease caused by a group of bacteria called Shigella.